Stock KALY KALI, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Kali, Inc.

Equities

KALY

US4833801016

Delayed OTC Markets
Other stock markets
 14:30:00 08/05/2024 BST 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for Kali, Inc. 0.00% 0.00%
2020 PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc.. CI
2020 PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc.. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alkame : PAO Group, Inc. Expands Its CBD Nutraceuticals Program; Three Products By EOY 2021 Targets $5 Billion Global Demand
AQ
Alkame : PAO Group, Inc.'s CBD Nutraceuticals Expected To Deliver Revenue-Generating Catalyst in 2021; New Partnerships Expand Its Long-Term CBD Pharmaceutical Programs
AQ
PAO Group, With A CRO On Its Side, Could Deliver Its First CBD-Based Therapeutic By Year's End
AQ
Kali : PAO Group, Inc. Rallies 21% On Monday; Investor Update This Morning Adds Fuel To Bullish Sentiment
AQ
PAOG Announces Opportunity To Expand CBD Pharmaceutical Research
NE
Alkame : PAO Group, Inc. Has Two CBD-Based Therapeutics In Play; Planned Launch For One In September Puts Catalyst In Play
AQ
Alkame : Catalyst From PAO Group Inc.'s CBD-Based Therapeutics Program In Play; Accelerates RespRx R&D Program
AQ
Puration Inc :.'s Stock Is In Bull Market Mode; Acquisitions And Strong Revenues Kick Off Big Start To 2021
AQ
PAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update Tomorrow
NE
PAOG Confirms Cannabis Biopharmaceutical Strategic Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021
NE
PAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2020
NE
PAOG Confirms Q4 2020 Revenue from Cannabis Asset Acquisition
NE
PAOG Expects to Report First Post Acquisition Revenue in Q4 2020
NE
Kali : PAOG Announces CRO Agreement To Advance Respiratory Cannabis Treatment Through Regulatory Approval
PR
Kali : PAOG - New Independent CBD Research Appears To Support PAOG RespRx Research
PR
Kali : PAOG FDA Application Process For Respiratory Cannabis Drug Treatment Update Scheduled This Friday
PR
PAOG and PURA Announce Free Hemp Seed Giveaway To Promote CBD and Hemp Awareness
NE
PAOG Engages Saul Kaye, Founder of iCAN: Israel-Cannabis and CannaTech to Prepare RespRx for IND
NE
PAOG Cannabis Pharmaceutical Research Initiative Gains New Traction
NE
PAOG Expands Cannabis Pharma Treatment Research
NE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KALY Stock
  4. News Kali, Inc.